Today’s top gainers include the company Medivation, Inc. (NASDAQ:MDVN) which is in the industry Biotechnology, gaining 0.02% today. In the last week its performance is 0.67%, and 40.92% for the past quarter. Currently, Medivation, Inc., MDVN has a target price of 77.79, so today’s gain of 0.02% is a significant step towards its target price. The GAP today is therefore 0.02%.
Medivation, Inc. (NASDAQ:MDVN), has a market cap of 13517.49, and is based in USA. Insider ownership is at 1.17%, and institutional ownership is 95.50%.
At the current price of 81.44, it has a dividend yield of *TBA, and its target price is 77.79. This is with a profit margin of *TBA, and total debt/equity of *TBA. Medivation, Inc. (NASDAQ:MDVN) has a P/E of *TBA, as well as a forward P/E of 36.36.
With a current EPS of -1.08, and a forecasted EPS growth for next year at 76.40%,Medivation, Inc. (NASDAQ:MDVN) has had a EPS growth for the past five years at 0.00%. For the next five years EPS growth is projected to be 38.00%.
Performance for the year is 104.47%. Since its IPO date on 1/13/1997, the total performance to date is 68.47%.
Volume today for Medivation, Inc. (NASDAQ:MDVN), is 7187400, while its average volume is 4290.32. Whilst the total gain today was 0.02%, it did have a day high of -0.05%.
Volatility for this week has been at 0.11%, and 0.23% for the month. The 52-week low for Medivation, Inc., MDVN has been 208.37%, while the 52-week-high has reached -0.05%.
Looking at its return of investments, which is *TBA, and its return on assets is *TBA. Medivation, Inc. (NASDAQ:MDVN) has an operating margin of *TBA. With a sales growth of 17.40% quarter over quarter. Bearing in mind that Medivation, Inc., MDVN is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Medivation, Inc.? Well its PEG is *TBA, and the P/S is 13.16, along with a P/B of 25.26. Meanwhile it has a p/cash of *TBA.